Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 20,245	$ 16,557
Restricted cash	386	0
Accounts receivable, net	12,136	13,973
Inventory	10,523	6,493
Prepaid expenses and other current assets	2,823	2,921
Total current assets	46,113	39,944
Property and equipment, net	102	377
Right of use assets, net	138	937
Intangible assets, net	975	2,210
Other assets	2,187	655
Total assets	49,515	44,123
Current liabilities:
Accounts payable	11,281	13,679
Accrued and other expenses	16,378	15,051
Current portion of deferred revenues	1,404	1,166
Line of credit	6,263	9,250
Current portion of long-term and other debt	1,103	5,944
Total current liabilities	36,429	45,090
Long-term debt, net	4,331	0
Common stock warrant liabilities	25,343	27,781
Other long-term liabilities	226	928
Total liabilities	66,329	73,799
Commitments and contingencies (Note 7)
Mezzanine equity:
Mezzanine equity	12,937	7,855
Stockholders’ deficit:
Common stock, $0.0001 par value, 107,142,857 shares authorized as of December 31, 2024 and December 31, 2023; 15,725,783 and 8,797,456 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	2	1
Additional paid-in capital	238,442	218,127
Accumulated deficit	(268,195)	(255,659)
Total stockholders’ deficit	(29,751)	(37,531)
Total liabilities, mezzanine equity, and stockholders’ deficit	49,515	44,123
Series A Convertible Preferred Stock
Mezzanine equity:
Mezzanine equity	5,151	7,855
Series B Convertible Preferred Stock
Mezzanine equity:
Mezzanine equity	3,452	0
Redeemable Common Stock
Mezzanine equity:
Mezzanine equity	$ 4,334	$ 0